Diferencia entre revisiones de «GLP-1 receptor agonist toxicity»
Sin resumen de edición |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
==Background== | ==Background== | ||
*GLP-1 receptor agonists (e.g., semaglutide) are injectable medication used for diabetes management and weight loss | |||
*Poison control centers have reported increasing inquiries related to possible overdoses | |||
==Clinical Features== | ==Clinical Features== | ||
Revisión del 20:05 31 ene 2024
Background
- GLP-1 receptor agonists (e.g., semaglutide) are injectable medication used for diabetes management and weight loss
- Poison control centers have reported increasing inquiries related to possible overdoses